[English] 日本語
Yorodumi- EMDB-74451: Cryo-EM structure of human UDP-N-acetylglucosamine-dolichyl-phosp... -
+
Open data
-
Basic information
| Entry | ![]() | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | Cryo-EM structure of human UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase (DPAGT1) in complex with APPB, composite map | ||||||||||||
Map data | Composite Map from Local Refinements of Chains A and B | ||||||||||||
Sample |
| ||||||||||||
Keywords | polyprenyl-phosphate N-acetylhexosamine phosphate transferase / phosphoglycosyltransferase / membrane protein / TRANSFERASE | ||||||||||||
| Function / homology | Function and homology informationBiosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein / Defective DPAGT1 causes CDG-1j, CMSTA2 / UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase / UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity / UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity / dolichol-linked oligosaccharide biosynthetic process / protein N-linked glycosylation / glycosyltransferase activity / intracellular membrane-bounded organelle / endoplasmic reticulum membrane ...Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein / Defective DPAGT1 causes CDG-1j, CMSTA2 / UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase / UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity / UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity / dolichol-linked oligosaccharide biosynthetic process / protein N-linked glycosylation / glycosyltransferase activity / intracellular membrane-bounded organelle / endoplasmic reticulum membrane / metal ion binding / identical protein binding / membrane Similarity search - Function | ||||||||||||
| Biological species | Homo sapiens (human) | ||||||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 2.9 Å | ||||||||||||
Authors | Kirsh JM / Ochoa JM / Soroush-Pejrimovsky MT / Kaudeer BY / Clemons WM | ||||||||||||
| Funding support | United States, 3 items
| ||||||||||||
Citation | Journal: bioRxiv / Year: 2025Title: Structures of bacterial and human phosphoglycosyltransferases bound to a common inhibitor inform selective therapeutics. Authors: Beebee Yusrah Kaudeer / Jacob M Kirsh / Katsuhiko Mitachi / Jessica M Ochoa / Marie-Therese Soroush-Pejrimovsky / Yancheng E Li / Vy N Nguyen / Michio Kurosu / William M Clemons / ![]() Abstract: Glycoconjugates facilitate myriad biological processes, including cell-cell recognition and immune response, and they are generated by enzymes that transfer glycans. The orthologs MraY and DPAGT1 are ...Glycoconjugates facilitate myriad biological processes, including cell-cell recognition and immune response, and they are generated by enzymes that transfer glycans. The orthologs MraY and DPAGT1 are dimeric phosphoglycosyltransferases involved in oligosaccharide biosynthesis for either bacterial peptidoglycan or eukaryotic -linked glycans, respectively. Both enzymes play central regulatory roles, making them attractive targets for antibacterial and anticancer therapies. In our prior studies, a muraymycin A1-derived inhibitor termed APPB (aminouridyl phenoxypiperidinbenzyl butanamide) was developed. It exhibits sub-100 nM IC50 values against both MraY and DPAGT1 and has demonstrated efficacy against DPAGT1-dependent cancers, making it an excellent starting point for next-generation small molecules. To guide inhibitor development, we determined cryo-EM structures of APPB bound to MraY or DPAGT1 at 2.9 Å resolution using single-particle analysis. The structures reveal that APPB, composed of a nucleoside, a central amide, and a lipid-mimetic, adopts two conformations in each protein, which correlate with local hydrogen-bonding contacts of the central amide carbonyl. Examination of the amide carbonyl environments guides conformer selection for future DPAGT1-targeting anticancer agents. Further, comparisons of APPB-bound geometries and nucleoside interactions inform opportunities for antibacterial agents targeting MraY. Overall, our study provides design principles for MraY- or DPAGT1-specific drugs and motivates the utility of simultaneously characterizing inhibitor-bound orthologs for selective therapeutics. | ||||||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_74451.map.gz | 2.5 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-74451-v30.xml emd-74451.xml | 18.9 KB 18.9 KB | Display Display | EMDB header |
| Images | emd_74451.png | 37.6 KB | ||
| Filedesc metadata | emd-74451.cif.gz | 6.8 KB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-74451 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-74451 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 9znnMC ![]() 9znoC C: citing same article ( M: atomic model generated by this map |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|
-
Map
| File | Download / File: emd_74451.map.gz / Format: CCP4 / Size: 421.9 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Composite Map from Local Refinements of Chains A and B | ||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.65 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-
Sample components
-Entire : Human UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosam...
| Entire | Name: Human UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase (DPAGT1) in complex with APPB |
|---|---|
| Components |
|
-Supramolecule #1: Human UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosam...
| Supramolecule | Name: Human UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase (DPAGT1) in complex with APPB type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1 Details: DPAGT1 incubated with small molecule APPB for one hour on ice |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 100.312 KDa |
-Macromolecule #1: UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosamineph...
| Macromolecule | Name: UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase type: protein_or_peptide / ID: 1 Details: Expressed as fusion protein with C-terminal TEV cleavage site followed by GFP; GFP was cleaved using TEV protease Number of copies: 2 / Enantiomer: LEVO EC number: UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 47.312938 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: MWAFSELPMP LLINLIVSLL GFVATVTLIP AFRGHFIAAR LCGQDLNKTS RQQIPESQGV ISGAVFLIIL FCFIPFPFLN CFVKEQCKA FPHHEFVALI GALLAICCMI FLGFADDVLN LRWRHKLLLP TAASLPLLMV YFTNFGNTTI VVPKPFRPIL G LHLDLGIL ...String: MWAFSELPMP LLINLIVSLL GFVATVTLIP AFRGHFIAAR LCGQDLNKTS RQQIPESQGV ISGAVFLIIL FCFIPFPFLN CFVKEQCKA FPHHEFVALI GALLAICCMI FLGFADDVLN LRWRHKLLLP TAASLPLLMV YFTNFGNTTI VVPKPFRPIL G LHLDLGIL YYVYMGLLAV FCTNAINILA GINGLEAGQS LVISASIIVF NLVELEGDCR DDHVFSLYFM IPFFFTTLGL LY HNWYPSR VFVGDTFCYF AGMTFAVVGI LGHFSKTMLL FFMPQVFNFL YSLPQLLHII PCPRHRIPRL NIKTGKLEMS YSK FKTKSL SFLGTFILKV AESLQLVTVH QSETEDGEFT ECNNMTLINL LLKVLGPIHE RNLTLLLLLL QILGSAITFS IRYQ LVRLF YDVGSSASEN LYFQ UniProtKB: UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase |
-Macromolecule #2: 4-({(2S,3S)-1-amino-3-{[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydro...
| Macromolecule | Name: 4-({(2S,3S)-1-amino-3-{[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy}-3-[(2S,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxyoxolan-2-yl]-1-oxopropan-2-yl}amino) ...Name: 4-({(2S,3S)-1-amino-3-{[(2S,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy}-3-[(2S,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxyoxolan-2-yl]-1-oxopropan-2-yl}amino)-N-[(4-{4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl}phenyl)methyl]butanamide (non-preferred name) type: ligand / ID: 2 / Number of copies: 2 / Formula: A1C3G |
|---|---|
| Molecular weight | Theoretical: 881.849 Da |
-Macromolecule #3: (2R)-3-{[(S)-[(2R)-2,3-dihydroxypropoxy](hydroxy)phosphoryl]oxy}-...
| Macromolecule | Name: (2R)-3-{[(S)-[(2R)-2,3-dihydroxypropoxy](hydroxy)phosphoryl]oxy}-2-{[(9Z)-octadec-9-enoyl]oxy}propyl (9Z)-octadec-9-enoate type: ligand / ID: 3 / Number of copies: 2 / Formula: A1C3H |
|---|---|
| Molecular weight | Theoretical: 775.044 Da |
-Macromolecule #4: water
| Macromolecule | Name: water / type: ligand / ID: 4 / Number of copies: 80 / Formula: HOH |
|---|---|
| Molecular weight | Theoretical: 18.015 Da |
| Chemical component information | ![]() ChemComp-HOH: |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Concentration | 4.0 mg/mL |
|---|---|
| Buffer | pH: 7.5 Details: 50 mM HEPES pH 7.5, 200 mM NaCl, 5 mM MgCl2, 0.022% (w/v) DDM, and 2 mM TCEP |
| Grid | Model: Quantifoil R1.2/1.3 / Material: COPPER / Mesh: 300 / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 75 sec. / Pretreatment - Pressure: 30.0 kPa |
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 277 K / Instrument: FEI VITROBOT MARK IV Details: 2-3 uL of sample distributed on grid with blot force +8 and blot time 3 seconds. |
| Details | DPAGT1 incubated with 0.4 mM APPB on ice for 1 hour |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Specialist optics | Energy filter - Slit width: 20 eV |
| Image recording | Film or detector model: GATAN K3 (6k x 4k) / Number grids imaged: 1 / Average electron dose: 70.0 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 3.0 µm / Nominal defocus min: 1.0 µm |
| Sample stage | Cooling holder cryogen: NITROGEN |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
+
Image processing
-Atomic model buiding 1
| Refinement | Space: REAL / Protocol: RIGID BODY FIT / Overall B value: 79.7 |
|---|---|
| Output model | ![]() PDB-9znn: |
Movie
Controller
About Yorodumi



Keywords
Homo sapiens (human)
Authors
United States, 3 items
Citation





Z (Sec.)
Y (Row.)
X (Col.)





















FIELD EMISSION GUN
